AchieveRx Reports Third Quarter 2026 Financial Results
AchieveRx, formerly Achieve Life Sciences, reported its financial results for the third quarter of 2026 and provided updates on its clinical and commercial progress.
Stocks · News reference
Achieve Life Sciences, Inc. announced that its Board of Directors' Compensation Committee approved equity awards for three new employees.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
AchieveRx, formerly Achieve Life Sciences, reported its financial results for the third quarter of 2026 and provided updates on its clinical and commercial progress.
Achieve Life Sciences, Inc. has rebranded as AchieveRx™, The Quit Company™, and will transition its Nasdaq ticker symbol to 'QUIT' effective November 10, 2026.
Achieve Life Sciences presented 52-week data for its cytisinicline program, which is being developed as a treatment for nicotine dependence, at the CHEST 2026 annual meeting.